Do you want to read an article? Please log in or register.
Changes in Mucociliary Clearance Over Time in Children with Cystic Fibrosis
Pulmonary Fibrosis
RECOMMENDED
Related content
Lung clearance index to monitor treatment response in pulmonary exacerbations in preschool children with cystic fibrosis
Thorax.
Rayment JH, Stanojevic S, Davis SD, Retsch-Bogart G, Ratjen F
doi: 10.1136/
RECOMMENDED
Pulmonary Fibrosis
Lung Clearance Index to Track Acute Respiratory Events in School-age Children with Cystic Fibrosis
★ 3
Recommended by
Dr Martin Frey, Faculty Member
Am J Respir Crit Care Med.
Perrem L, Stanojevic S, Shaw M, Jensen R, McDonald N, Isaac SM, Davis M, Clem C, Guido J, Jara S, France L, Solomon M, Grasemann H, Waters V, Sweezey N, Sanders DB, Davis SD, Ratjen F
doi: 10.1164/rccm.202006-2433OC.Visit the original publication at ncbi.nlm.nih.gov
RECOMMENDED
Pulmonary Fibrosis
Longitudinal Course of Clinical Lung Clearance Index in Children with Cystic Fibrosis
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir J
Frauchiger BS, Binggeli S, Yammine S, Spycher B, Krüger L, Ramsey KA, Latzin P
doi: 10.1183/13993003.02686-2020
Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study
Lancet Respir Med.
Rosenfeld M, Wainwright CE, Higgins M, Wang LT, McKee C, Campbell D, Tian S, Schneider J, Cunningham S, Davies JC; ARRIVAL study group
doi: 10.1016/S2213-
RECOMMENDED
Pulmonary Fibrosis
Determinants of lung disease progression measured by lung clearance index in children with cystic fibrosis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir J
Stanojevic S, Davis SD, Perrem L, Shaw M, Retsch-Bogart G, Davis M, Jensen R, Clem CC, Isaac SM, Guido J, Jara S, France L, McDonald N, Solomon M, Sweezey N, Grasemann H, Waters V, Sanders DB, Ratjen FA
doi: 10.1183/13993003.03380-2020
Pulmonary Fibrosis
Short-Term Effects of Elastic Chest Wall Restriction on Pulmonary Function in Children with Cystic Fibrosis
Respiration.
Roethlisberger K, Nyilas S, Riedel T, Wolfensberger J, Singer F, Latzin P
doi: 10.1159/000491094.
Initial acquisition and succession of the cystic fibrosis lung microbiome is associated with disease progression in infants and preschool children
PLoS Pathog.
Muhlebach MS, Zorn BT, Esther CR, Hatch JE, Murray CP, Turkovic L, Ranganathan SC, Boucher RC, Stick SM, Wolfgang MC
doi: 10.1371/
Pulmonary Fibrosis
Children with cystic fibrosis demonstrate no respiratory immunological, infective or physiological, consequences of vitamin D deficiency
J Cyst Fibros.
Thursfield RM, Naderi K, Leaver N, Rosenthal M, Alton EWFW, Bush A, Davies JC
doi: 10.1016/j.jcf.2018.02.011.
RECOMMENDED
Pulmonary Fibrosis
Safety, pharmacokinetics, and pharmacodynamics of lumacaftor and ivacaftor combination therapy in children aged 2-5 years with cystic fibrosis homozygous for F508del-CFTR: an open-label phase 3 study
Lancet Respir Med.
McNamara JJ, McColley SA, Marigowda G, Liu F, Tian S, Owen CA, Stiles D, Li C, Waltz D, Wang LT, Sawicki GS
doi: 10.1016/S2213-2600(18)30460-0.